-
1
-
-
0024836218
-
The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimens
-
1. Schmoll H-J. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimens. Eur J Cancer Clin Oncol 1989, 25 (Suppl. 1), S35-S39.
-
(1989)
Eur J Cancer Clin Oncol
, vol.25
, Issue.SUPPL. 1
-
-
Schmoll, H.-J.1
-
2
-
-
0025192890
-
3 (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis
-
3 (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990, 322, 816-821.
-
(1990)
N Engl J Med
, vol.322
, pp. 816-821
-
-
Marty, M.1
Pouillart, P.2
Scholl, S.3
-
3
-
-
0014734676
-
Dystonic reactions in children caused by metoclopramide
-
3. Casteels-Van Daele M, Jaeken J, Van Der Schueren M, et al. Dystonic reactions in children caused by metoclopramide. Arch Dis Child 1970, 45, 130-133.
-
(1970)
Arch Dis Child
, vol.45
, pp. 130-133
-
-
Casteels-Van Daele, M.1
Jaeken, J.2
Van Der Schueren, M.3
-
4
-
-
0019564207
-
Metoclopramide poisoning in children
-
4. Casteels-Van Daele M. Metoclopramide poisoning in children. Arch Dis Child 1981, 56, 406-407.
-
(1981)
Arch Dis Child
, vol.56
, pp. 406-407
-
-
Casteels-Van Daele, M.1
-
5
-
-
0020661253
-
The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis
-
5. Wampler G. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 1983, 25 (Suppl. 1), 35-51.
-
(1983)
Drugs
, vol.25
, Issue.SUPPL. 1
, pp. 35-51
-
-
Wampler, G.1
-
6
-
-
0021807752
-
Metoclopramide: Dose-related toxicity and preliminary anti-emetic studies in children receiving cancer chemotherapy
-
6. Allen JC, Gralla RJ, Reilly LK, et al. Metoclopramide: dose-related toxicity and preliminary anti-emetic studies in children receiving cancer chemotherapy. J Clin Oncol 1985, 3, 1136-1141.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1136-1141
-
-
Allen, J.C.1
Gralla, R.J.2
Reilly, L.K.3
-
7
-
-
0021321139
-
Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy
-
7. Terrin BN, McWilliams NB, Maurer HM. Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatr 1984, 104, 138-140.
-
(1984)
J Pediatr
, vol.104
, pp. 138-140
-
-
Terrin, B.N.1
McWilliams, N.B.2
Maurer, H.M.3
-
8
-
-
0021204571
-
Paradoxical effects of prophylactic phenothiazine anti-emetics in children receiving chemotherapy
-
8. Zeltzer L, Le Baron S, Zeltzer PM. Paradoxical effects of prophylactic phenothiazine anti-emetics in children receiving chemotherapy. J Clin Oncol 1984, 2, 930-936.
-
(1984)
J Clin Oncol
, vol.2
, pp. 930-936
-
-
Zeltzer, L.1
Le Baron, S.2
Zeltzer, P.M.3
-
9
-
-
0022644319
-
Metoclopramide as an antiemetic agent in paediatric oncology patients
-
9. Howrie DL, Felix C, Wollman M, et al. Metoclopramide as an antiemetic agent in paediatric oncology patients. DICP 1986, 20, 122-124.
-
(1986)
DICP
, vol.20
, pp. 122-124
-
-
Howrie, D.L.1
Felix, C.2
Wollman, M.3
-
10
-
-
84870858083
-
Refusal of further cancer chemotherapy due to antiemetic drug
-
10. Casteels-Van Daele M, Dobosz-Cyclis R, Van de Casseye W, et al. Refusal of further cancer chemotherapy due to antiemetic drug. Lancet 1984, 1, 57.
-
(1984)
Lancet
, vol.1
, pp. 57
-
-
Casteels-Van Daele, M.1
Dobosz-Cyclis, R.2
Van De Casseye, W.3
-
11
-
-
0011883631
-
Ondansetron for chemotherapy-induced emesis in children. A Benelux study
-
11. Brock PR, Bokkerink JPM, Tamminga RYJ, et al. Ondansetron for chemotherapy-induced emesis in children. A Benelux study. Int J Ped Haematol/Oncol 1994, 1, 235-240.
-
(1994)
Int J Ped Haematol/Oncol
, vol.1
, pp. 235-240
-
-
Brock, P.R.1
Bokkerink, J.P.M.2
Tamminga, R.Y.J.3
-
12
-
-
0024999519
-
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia
-
12. Carden PA, Mitchell SL, Waters KD, et al. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia. J Clin Oncol 1990, 8, 1531-1535.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1531-1535
-
-
Carden, P.A.1
Mitchell, S.L.2
Waters, K.D.3
-
13
-
-
0025194924
-
3 antagonist ondansetron-an effective outpatient anti-emetic in cancer treatment
-
3 antagonist ondansetron-an effective outpatient anti-emetic in cancer treatment. Arch Dis Child 1990, 65, 822-825.
-
(1990)
Arch Dis Child
, vol.65
, pp. 822-825
-
-
Pinkerton, C.R.1
Williams, D.2
Wootton, C.3
-
14
-
-
0026674728
-
Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children
-
14. Jurgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 1992, 49, 279-285
-
(1992)
Oncology
, vol.49
, pp. 279-285
-
-
Jurgens, H.1
McQuade, B.2
-
15
-
-
0027447480
-
The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children
-
15. Hewitt M, McQuade B, Stevens R. The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children. Clin Oncol R Coll Radiol 1993, 5, 11-14.
-
(1993)
Clin Oncol R Coll Radiol
, vol.5
, pp. 11-14
-
-
Hewitt, M.1
McQuade, B.2
Stevens, R.3
-
17
-
-
0027081530
-
Stratified, randomised, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting
-
17. Beck TM, Hesketh PJ, Madajewicz S, et al. Stratified, randomised, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 1992, 10, 1969-1975.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1969-1975
-
-
Beck, T.M.1
Hesketh, P.J.2
Madajewicz, S.3
-
18
-
-
0001149425
-
Efficacy, pharmacokinetics (PK) and safety of ondansetron (OND) in pediatric chemotherapy patients (PTS)
-
Abs PII-49
-
18. Bryson JC, Pritchard JF, Shurin S, et al. Efficacy, pharmacokinetics (PK) and safety of ondansetron (OND) in pediatric chemotherapy patients (PTS). Clin Pharmacol Ther 1991, 49(2), 161 Abs PII-49.
-
(1991)
Clin Pharmacol Ther
, vol.49
, Issue.2
, pp. 161
-
-
Bryson, J.C.1
Pritchard, J.F.2
Shurin, S.3
-
19
-
-
0025326415
-
Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting
-
19. Cubeddu LX, Hoffmann IS, Fuenmayor NT, et al. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990, 322, 810-816.
-
(1990)
N Engl J Med
, vol.322
, pp. 810-816
-
-
Cubeddu, L.X.1
Hoffmann, I.S.2
Fuenmayor, N.T.3
-
20
-
-
0021994999
-
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin
-
20. Kris MG, Gralla RJ, Clark RA, et al. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985, 3, 1379-1384.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1379-1384
-
-
Kris, M.G.1
Gralla, R.J.2
Clark, R.A.3
-
21
-
-
0027182889
-
Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatin-based chemotherapy: Effects of anti-emetics
-
21. Cubeddu LX, Hoffmann IS. Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatin-based chemotherapy: effects of anti-emetics. J Clin Pharmacol 1993, 33, 691-697.
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 691-697
-
-
Cubeddu, L.X.1
Hoffmann, I.S.2
-
22
-
-
85030272608
-
Measurement of urinary 5-hydroxyindolacetic acid in children receiving cisplatin by 24-hour infusion
-
Ch. 4, Catholic University of Leuven, Belgium
-
22. Brock P. Measurement of urinary 5-hydroxyindolacetic acid in children receiving cisplatin by 24-hour infusion. In Cisplatin Toxicity in Infants and Children. Acta Medica Lovaniensia 102, Ch. 4, Catholic University of Leuven, Belgium, 1994.
-
(1994)
Cisplatin Toxicity in Infants and Children. Acta Medica Lovaniensia
, vol.102
-
-
Brock, P.1
-
23
-
-
0025745215
-
Progress in the control of acute and delayed emesis induced by cisplatin
-
23. Gandara DR. Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 1991, 27 (Suppl. 1), S9-S11.
-
(1991)
Eur J Cancer
, vol.27
, Issue.SUPPL. 1
-
-
Gandara, D.R.1
-
24
-
-
0025888322
-
Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
-
24. Smyth JF, Coleman RE, Nicolson M, et al. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? Br Med J 1991, 303, 1423-1426.
-
(1991)
Br Med J
, vol.303
, pp. 1423-1426
-
-
Smyth, J.F.1
Coleman, R.E.2
Nicolson, M.3
-
25
-
-
0027460629
-
Role of ondansetron plus dexamethasone in fractionated chemotherapy
-
25. Rath U, Upadhyaya BK, Arechavala E, et al. Role of ondansetron plus dexamethasone in fractionated chemotherapy. Oncology 1993, 50, 168-172.
-
(1993)
Oncology
, vol.50
, pp. 168-172
-
-
Rath, U.1
Upadhyaya, B.K.2
Arechavala, E.3
-
26
-
-
0025800103
-
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
-
26. Smith DB, Newlands ES, Rustin GJS, et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991, 338, 487-190.
-
(1991)
Lancet
, vol.338
, pp. 487-1190
-
-
Smith, D.B.1
Newlands, E.S.2
Rustin, G.J.S.3
-
27
-
-
0026071703
-
Prevention of cisplatin-induced emesis: A double-blind multicenter randomised crossover study comparing ondansetron and ondansetron plus dexamethasone
-
27. Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomised crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991, 9, 675-678.
-
(1991)
J Clin Oncol
, vol.9
, pp. 675-678
-
-
Roila, F.1
Tonato, M.2
Cognetti, F.3
-
28
-
-
0028438169
-
Cost effectiveness analysis of anti-emetic treatment
-
28. Bleiberg H, Autier P, Michaux M. Cost effectiveness analysis of anti-emetic treatment. Supp Care Cancer 1994, 2, 145-149.
-
(1994)
Supp Care Cancer
, vol.2
, pp. 145-149
-
-
Bleiberg, H.1
Autier, P.2
Michaux, M.3
|